<DOC>
	<DOCNO>NCT02075385</DOCNO>
	<brief_summary>General Objective : To evaluate swallow result speech pathologist rehabilitation advance oropharynges , larynx hypopharynx cancer patient neoadjuvant chemotherapy radiotherapy concomitant chemotherapy . Methods Casuistic : Randomized clinical trial phase II . 80 patient advanced oropharynges , larynx hypopharynx cancer diagnose Barretos Cancer Hospital , proposal neoadjuvant chemotherapy follow radiotherapy combine chemotherapy . Patients randomize two group : control group speech pathology therapy group</brief_summary>
	<brief_title>Swallowing Intervention During Radiochemotherapy Head Neck Cancer</brief_title>
	<detailed_description>To evaluate compare swallow life quality swallow group undergo speech pathology therapy ( intervention ) control group ( intervention ) .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Deglutition Disorders</mesh_term>
	<criteria>Head neck squamous cell carcinoma Indication protocol treatment neoadjuvant chemotherapy follow radiotherapy concomitant chemotherapy . Oropharynges , larynx hypopharynx advanced cancer ( T3 T4 ) , classify resectable ; 18 year old old ; inform consent sign specific procedure Previous head neck surgery Previous radiotherapy chemotherapy Previous history neoplasia , except situ carcinoma endometrial ( uterine ) cancer , skin basal cell squamous cell carcinoma ; Severe laryngeal aspiration consistency swallow evaluate thought videofluoroscopy Patients cognitive deficit could comprehend speech pathology intervention .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Dysphagia</keyword>
	<keyword>speech language therapy</keyword>
	<keyword>quality life</keyword>
	<keyword>induction chemotherapy</keyword>
	<keyword>concurrent chemoradiotherapy</keyword>
</DOC>